What is the difference between Harvest® PRP and other PRP technologies?  What is Harvest® PRP / PRF?

Harvest® PRP / PRF The Gold Standard in PRP Technology for over Two Decades

The Harvest® Terumo SmartPrep® Platelet Concentrate System was the first commercial, point-of-care system approved for the rapid preparation of Platelet-Rich Plasma (PRP). Since its release over 20 years ago, the system and components have been continuously re-engineered with technology that follows emerging science in the field. Excellence in technology and outcomes is why the SmartPrep® Platelet Concentrate System is relied upon all over the world to produce highly concentrated Platelet-Rich Plasma with the optimal cellular composition.

Optimizing the Cellular Composition of PRP Solution

The Harvest PRP process disposable includes a proprietary, self-calibrating floating shelf for concentrating platelets and optimizing the cellular composition of the final PRP solution. The floating shelf used in the SmartPrep PRP processing disposable is specifically designed to increase platelet yield and selectively capture the mononuclear fraction of the WBC population.

The mononuclear WBC fraction contains many peripheral stem cells, identified by the CD34+ marker. CD34+ cells aid in angiogenesis and tissue regeneration at the application site. The concentration of stem cells found in PRP prepared on the Harvest Terumo SmartPrep® system is indicated by the presence of CD34+ cells.

Harvest® PRP typically has 10 to 20 times more platelets compared to the 12 other PRP technologies currently available on the market. Thus, Harvest PRP has 10 to 20 times more of the essential growth factors for stimulating collagen growth. Harvest® double spin methods produce significantly more platelet with higher concentrations of growth factors.

PRP is produced using the Harvest® SmartPrep® Multicellular Processing System, which delivers the highest concentration and yield of platelets when compared to a multitude of other systems.  Test tube systems, Lab centrifuges and many other commercially available “PRP” systems fail to achieve the threshold of platelet concentration and white blood cell composition required for optimal tissue regeneration.